CYPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
CYPHERPUNK TECHNOLOGIES INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.53−0.04 (-1.56%)
Close on Oct 19, 2026
- Market cap
- $549.88M
- P/E (TTM)
- 36.1
- Dividend yield
- –
Share price
+$1.98 (+358.7%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $549.88M
- P/E ratio
- 36.1
- Price to sales
- –
- Price to book
- 3.95
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$877.00K
- EPS, diluted
- $0.07
- Book value per share
- $0.64
- Diluted shares
- 217M
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$17.78M
Net income
-$877.00K
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months